"Differences in Treatment Patterns and Health Care Costs among Non-Hodgkin’s Lymphoma and Chronic Lymphocytic Leukemia Patients Receiving Rituximab in the Hospital Outpatient Setting versus the Office/Clinic Setting"
written by Anatole A. Klyosov, Igor L. Rozhanskii,
published by Journal of Cancer Therapy, Vol.5 No.2, 2014
has been cited by the following article(s)：
Does site-of-care for oncology infusion therapy influence treatment patterns, cost, and quality in the United States?
Critical Reviews in Food Science and Nutrition 2017